Flagship Ventures Fund V L.P. 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-13 5:09 pm Purchase | 2026-01-09 | 13D | Foghorn Therapeutics Inc. FHTX | Flagship Ventures Fund V L.P. | 20,774,885 27.200% | 20,774,885 (New Position) | Filing |